Home › Funds › RTW INVESTMENTS, LP › URGN
RTW INVESTMENTS, LP position in URGN
UROGEN PHARMA LTD · Health Care
RTW INVESTMENTS, LP reported holding 4,543,895 shares of URGN (UROGEN PHARMA LTD) in its Q3 2026 13F filing — a position valued at US$184.6M, representing 1.86% of its reported portfolio and ranking #18 among its reported holdings. RTW INVESTMENTS, LP has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's URGN position evolved
RTW INVESTMENTS, LP first disclosed a stake in URGN in Q3 2023 at 857,464 shares (US$12.0M). The position peaked in Q3 2026 at 4,543,895 shares, worth US$184.6M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 4,543,895 shares valued at US$184.6M. Notable position changes include a 101% increase in Q4 2023 (shares were roughly flat over the following quarter), a 89% increase in Q1 2024 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 857.46K | $12.01M | New |
| Q4 2023 | 1.73M | $25.90M | Add |
| Q1 2024 | 3.26M | $48.86M | Add |
| Q2 2024 | 3.56M | $59.69M | Add |
| Q3 2024 | 3.79M | $48.10M | Add |
| Q4 2024 | 3.83M | $40.84M | Add |
| Q1 2025 | 3.83M | $42.41M | Hold |
| Q2 2025 | 4.54M | $62.25M | Add |
| Q3 2025 | 4.54M | $90.65M | Hold |
| Q4 2025 | 4.54M | $106.42M | Hold |
| Q1 2026 | 4.54M | $81.70M | Hold |
| Q2 2026 | 4.54M | $167.22M | Hold |
| Q3 2026 | 4.54M | $184.62M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About URGN and 13F data
URGN (UROGEN PHARMA LTD) is a Health Care company. 46 other funds we track also report a position in URGN — the largest reported positions include Kynam Capital Management, LP (US$98.9M), Jefferies Financial Group Inc. (US$89.4M), ACORN CAPITAL ADVISORS, LLC (US$67.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding URGN
- Kynam Capital Management, LP 2.43M sh · $98.90M · Q3 2026
- Jefferies Financial Group Inc. 2.20M sh · $89.37M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 1.65M sh · $66.98M · Q3 2026
- Opaleye Management Inc. 1.44M sh · $52.99M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.15M sh · $46.67M · Q3 2026
- MPM BioImpact LLC 933.41K sh · $34.35M · Q2 2026
- Soleus Capital Management, L.P. 829.81K sh · $30.54M · Q2 2026
- Parkman Healthcare Partners LLC 750.20K sh · $30.48M · Q3 2026
- Boxer Capital Management, LLC 500.00K sh · $18.40M · Q2 2026
- ADAR1 Capital Management, LLC 369.79K sh · $15.02M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 297.08K sh · $12.07M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 184.39K sh · $7.49M · Q3 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held URGN?
RTW INVESTMENTS, LP has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in URGN?
As of Q3 2026, RTW INVESTMENTS, LP holds 4.54M shares of URGN (UROGEN PHARMA LTD), valued at $184.62M, representing 1.86% of its reported portfolio and ranking #18.
Has RTW INVESTMENTS, LP been buying or selling URGN?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in URGN. The position peaked in Q3 2026 at 4.54M shares.
Which other funds hold URGN?
Other major institutional holders of URGN include Kynam Capital Management, LP, Jefferies Financial Group Inc., ACORN CAPITAL ADVISORS, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.